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Introduction 
Soft tissue- and skin-related infections are great challenges in public health. Novel and alternative strategies 
to combat wounds colonized with resistant bacteria are urgently needed. Furthermore, many of the 
commercially available and clinically applied antimicrobial dressings are showing not the results as 
guaranteed. Shortening the time from lab developments to promising clinical applications and to bioevaluate 
already CE-marked products more reliable and reproducible without abusing unnecessarily test animals 
bioengineered, xenogen-free 3D human skin equivalents (HSE) as wound infection models are highly 
demanded. 
Experimental Methods 
Dermal and epidermal compartments were established by embedding human primary fibroblasts (NHDF) in 
recombinant human collagen type I (rhColl-I) hydrogels and then seeding human primary keratinocytes 
(NHEK) on it to generate the epidermis. The cultural conditions were optimized to obtain closely mimicking in 
vivo skin. Therefore, the biomechanical properties of different NHDF/rhColl-I combinations and clinical 
human dermis samples were tested and compared applying nanoindentation (Piuma, Optics11). Skin wound 
models with defined wound depths were created with a novel developed programmable punch device and 
colonized with relevant skin infectious bacteria e.g. S. aureus at wound site, to generate an in vitro skin 
infection model. The novel 100% xenogen-free human skin, wound and colonized wound models were fully 
characterized by histopathological methods, confocal microscopy, TEM analysis and nanoindentation. The 
infection model was validated by applying different antimicrobial wound dressings, testing cyto- and 
immunocompatibility and antimicrobial properties. 
Results and Discussion 
Different combinations of cell numbers (NHDF) and rhColl-I compositions led to dermis constructs with 
different biomechanical properties significantly influencing fibroblasts' metabolic activity and gene 
expression. "Instable" dermis constructs inhibited the cultivation and development of regular NHEK layers 
and prevent the formation of characteristic multilayered epidermal structures. With specific combinations, 
uniform distribution and filopodia like morphology of NHDFs stable 3D HSEs could be achieved. Morphology 
studies and uniform distribution of fibroblasts at different planes inside the dermal compartment were 
analysed by confocal imaging. Immunohistology and TEM were used to visualize the correct establishment 
of basement membranes (laminin 5 expression) and dermal-epidermal junctions. Proliferating NHEKs 
showed keratin 14 and keratin 10 in the corresponding layers. The establishment of standardized wounds 
and infected wound models is necessary for the reliable and reproducible analysis of antimicrobial wound 
dressings, their validation and comparison with each other. Figure 1 is representing a microscopic analysis 
of the HSE wound model after 24 h of incubation with Staph. aureus showing bacteria establishing colonies 
of different sizes within the dermis at wound site dissolving the matrix and surrounding layers of 
keratinocytes. Four different clinically applied silver-containing wound dressings were used to investigate 
differences in cytocompatibility and antimicrobial efficacy. The comparison of the evaluation results between 
common standardized cell culture and microbio tests with the 3D HSE wound infection model revealed 
significant differences regarding cytotoxic concentrations of the active component, here Ag+ ions, and the 
antimicrobial activity against susceptible described bacteria under more realistic conditions. 
Conclusion 
With our bioengineered, 100% xenogen-free 3D human skin equivalent it was possible to bioevaluate 
clinically applied silver-containing wound dressings and to demonstrate the significant differences of the 
materials' cytocompatibility and antibacterial properties in a more realistic biological microenvironment. This 
model as many other 3D tissue equivalents seems promising for its application in diverse areas of 
biomaterials research, including cytocompatibility evaluation, drug testing, wound healing and skin infection. 
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